Dr. Daniel E. Freedberg
Overview
Dr. Freedberg graduated from Harvard Medical School and completed his residency and fellowship training at Columbia University. He received a Master's degree in biostatistics from Columbia's Mailman School of Public Health. Dr. Freedberg's research focuses on the use of acid suppression medications, Clostridium difficile infection, and the gastrointestinal microbiome. Current projects include studies of how acid suppression medications alter the colonic microbiome and of how alterations in the gastrointestinal flora predispose patients to Clostridium difficile and other infections during periods of critical illness. His research is funded by the National Institutes of Health and the American Gastroenterological Association.Dr. Freedberg is a clinical and translational investigator focused on the relationship between the gastrointestinal microbiome and infections, both enteric and non-enteric. He is a graduate of Harvard Medical School and the Mailman School of Public Health and trained in medicine and gastroenterology at Columbia University Medical Center. He is the past recipient of an American Gastroenterological Association (AGA) Research Scholar Award and has received funding from the NIH/NIDDK, Irving Institute (Columbia's CTSA), and the Department of Defense. His work has been published in leading journals across disciplines: Gastroenterology, Clinical Infectious Disease, Intensive Care Medicine, JAMA Internal Medicine, and Nature. Currently, he focuses on the gastrointestinal microbiome in the intensive care unit (ICU). He has built large ICU cohorts containing longitudinal clinical data, serial rectal swabs, other biosamples, and clinical outcomes data. These samples and data have been collected to understand the dynamic changes that take place within the gastrointestinal microbiome during critical illness and to ask how these changes may impact risk for ICU-acquired infections. His past studies in this area show the importance of colonizing pathogens such as C. difficile and vancomycin-resistant Enterococcus (VRE) as determinants not only of the patient's own health but of outcomes for patients who share the same hospital environment. Ongoing research tests interventions seeking to improve the resistance of the native gut microbiota against pathogens, with a goal of preventing colonization and downstream infection in the ICU.
Dr. Freedberg is highly rated in 4 conditions, according to our data. His top areas of expertise are Pseudomembranous Colitis, Lower Esophageal Ring, Barrett Esophagus, Endoscopy, and Colonoscopy.
His clinical research consists of co-authoring 125 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
622 West 168th Street, New York, NY 10032
161 Fort Washington Avenue, New York, NY 10032
Additional Areas of Focus
Dr. Freedberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
CUIMC/Herbert Irving Pavilion
Bo Shen, MD, is one of the world’s pre-eminent leaders in interventional inflammatory bowel disease (IBD) and pouch-related disorders due to his specialized expertise and experience treating a wide range of these conditions. Dr. Shen is the director of the IBD Center at Columbia and co-director of Columbia’s Global Center for Integrated Colorectal Surgery and IBD Interventional Endoscopy. He is also the Vice Chair for Innovation in Medicine and Surgery and a Professor of Medicine (in Surgery) and Edelman-Jarislowsky Professor in Surgical Sciences.In addition to pouchitis and pouch diseases, Dr. Shen specializes in critical diagnostic evaluation, and medical and endoscopic management of IBD, GI endoscopy and imaging technology. Dr. Shen is known as a pioneer in interventional endoscopic therapy for IBD and ileal pouch disorders - this includes postponing or eliminating the need for surgery in some cases.Dr. Shen comes to Columbia/NewYork-Presbyterian from the Cleveland Clinic, where he served as medical director for the Center of Inflammatory Bowel Diseases and the Ed and Joey Story Endowed Chair, Digestive Disease and Surgery Institute. While there, Dr. Shen established a subspecialty Pouchitis Clinic and Interventional IBD Unite - the first and largest of its kind in the United States. He also created an IBD Board, modeled after oncology tumor boards, to help manage the most challenging cases with multiple specialists.A prolific researcher in the field with more than 600 peer-reviewed articles, Dr. Shen is funded by a number of government and philanthropic organizations, including the NIH, the American Gastroenterological Association, American College of Gastroenterology, the Broad Foundation, and the Crohn’s and Colitis Foundation of America. Dr. Shen is highly rated in 35 conditions, according to our data. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Ileostomy, and Endoscopy.
ColumbiaDoctors - Midtown
David Katzka is a Gastroenterologist in New York, New York. Dr. Katzka is highly rated in 18 conditions, according to our data. His top areas of expertise are Esophagitis, Eosinophilic Esophagitis, Barrett Esophagus, Endoscopy, and Gastrectomy.
Recanati Miller Transplantation Institute
Thomas Schiano is a Gastroenterologist in New York, New York. Dr. Schiano is highly rated in 31 conditions, according to our data. His top areas of expertise are Hepatitis, Hepatitis C, Autoimmune Hepatitis, Liver Transplant, and Splenectomy.
Frequently Asked Questions about Dr. Daniel E. Freedberg
How do I make an appointment with Dr. Daniel E. Freedberg?
You can book an appointment with Dr. Daniel E. Freedberg by calling their office at 646-317-3533. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Daniel E. Freedberg a top-rated expert for Pseudomembranous Colitis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel E. Freedberg is classified as an Advanced expert for Pseudomembranous Colitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Daniel E. Freedberg specialize in?
While Dr. Daniel E. Freedberg is a Gastroenterology, they have specific expertise in Pseudomembranous Colitis, Lower Esophageal Ring, and Barrett Esophagus. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.
Does Dr. Daniel E. Freedberg participate in research or clinical trials?
Yes. Dr. Daniel E. Freedberg has published 125 articles and abstracts on conditions like Pseudomembranous Colitis. You can view a list of Dr. Daniel E. Freedberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Daniel E. Freedberg accept my insurance?
Dr. Daniel E. Freedberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 646-317-3533 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Barrett EsophagusDr. Freedberg isAdvanced. Learn about Barrett Esophagus.
- Lower Esophageal RingDr. Freedberg isAdvanced. Learn about Lower Esophageal Ring.
- Pseudomembranous ColitisDr. Freedberg isAdvanced. Learn about Pseudomembranous Colitis.
- Viral GastroenteritisDr. Freedberg isAdvanced. Learn about Viral Gastroenteritis.
- Experienced
- AchalasiaDr. Freedberg isExperienced. Learn about Achalasia.
- Angiodysplasia of the ColonDr. Freedberg isExperienced. Learn about Angiodysplasia of the Colon.
- Bacterial GastroenteritisDr. Freedberg isExperienced. Learn about Bacterial Gastroenteritis.
- Celiac DiseaseDr. Freedberg isExperienced. Learn about Celiac Disease.
- Chronic Erosive GastritisDr. Freedberg isExperienced. Learn about Chronic Erosive Gastritis.
- ColitisDr. Freedberg isExperienced. Learn about Colitis.